相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
Serpin G1 / SERPING1 / C1IN抗体
抗体类型: Rabbit Polyclonal Antibody ( Antibody Purification Platform )
Ig Type : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, human cell-derived, recombinant human SerpinG1 ( rh SerpinG1 ; Catalog#10995-H08H ; NP_000053.2 ; Met 1 - Ala 500 ). Total IgG was purified by Protein A affinity chromatography.
Serpin G1 / SERPING1 / C1IN Antibody Background
Plasma protease C1 inhibitor, also known as C1-inhibiting factor, C1-INH, C1 esterase inhibitor, SERPING1 and C1IN, is a serine protease inhibitor protein. C1-INH is the largest member among the serpin class of proteins. Remarkably, C1-INH has a 2-domain structure, unlike most family members. The C-terminal serpin domain is similar to other serpins, and this part of C1-INH provides the inhibitory activity. The N-terminal domain is not essential for C1-INH to inhibit proteinases and has no similarity to other proteins. The main function of C1-INH is the inhibition of the complement system to prevent spontaneous activation. C1-INH is an acute phase protein and circulates in blood at levels of around 0.25 g/L, whose levels rise 2-fold during inflammation. C1-INH irreversibly binds to and inactivates C1r and C1s proteinases in the C1 complex of classical pathway of complement. C1-INH prevents the proteolytic cleavage of later complement components C4 and C2 by C1 and MBL. Although named after its complement inhibitory activity, C1-INH also inhibits proteinases of the fibrinolytic, clotting, and kinin pathways. Most notably, C1-INH is the most important physiological inhibitor of plasma kallikrein, fXIa and fXIIa.
Serpin G1 / SERPING1 / C1IN抗体相关产品如下:xy-9318R phospho-NEK9(Thr210)磷酸化丝氨酸/苏氨酸蛋白激酶NEK9抗体
xy-9319R NNF1R多胺调控因子1抗体
xy-9300R NNP1新型核蛋白质1抗体
xy-7080R Nucleolar protein 3核仁蛋白3抗体
xy-9625R NPAP1核孔蛋白1抗体
xy-4730R NADPH oxidase 4NADPH氧化酶4抗体
xy-9713R FAD24脂肪细胞分化因子24
xy-9468R Nebulette肌动蛋白结合蛋白Z盘状蛋白抗体
xy-9473R NFAT5活化T细胞核因子5蛋白抗体
xy-9474R phospho-NFAT5 (Ser1197)磷酸化活化T细胞核因子5蛋白抗体
xy-1373R Lipocalin 2脂质运载蛋白抗体
xy-1366R NF22型神经纤维瘤抗体
xy-8513R NIR1膜相关磷脂转运蛋白抗体
xy-0903R Natrexone纳曲酮抗体IgG
xy-3297R Phospho-NDRG1 (Ser330)磷酸化分化相关基因NDRG1抗体
xy-3298R Phospho-NDRG1 (Thr346)磷酸化分化相关基因NDRG1抗体
xy-3506R NEDD4L泛素连接酶NEDD4-2抗体
xy-3291R Phospho-NF2(Ser518)磷酸化2型神经纤维瘤抗体
xy-3302R Phospho-NMDAR1(Ser896)磷酸化谷氨酸受体1抗体
xy-3903R Phospho-NMDAR1 (Ser897)磷酸化谷氨酸受体1抗体
xy-11214R Nfasc186 神经束蛋白186抗体
xy-3299R Phospho-NEDD4L (Ser342)磷酸化泛素连接酶NEDD4-2抗体
xy-3300R Phospho-NFKB1 (Ser927)磷酸化细胞核因子p50/k基因结合核因子抗体
xy-3301R Phospho-NMDAR1 (Ser890)磷酸化谷氨酸受体1抗体
xy-3561R KAT13C类固醇受体激活蛋白2抗体
xy-0829R Nanog胚胎干细胞关键蛋白抗体
xy-1052R NAP1L1核小体组装蛋白1抗体
xy-1172R N-cadherinN-钙粘附分子抗体
xy-0224R NCoR1核受体辅助抑制因子1抗体
xy-0513R Nephrin肾小球细胞粘附分子受体抗体
xy-0006R Nestin巢蛋白/神经上皮干细胞蛋白抗体
xy-0008R Nestin巢蛋白/神经上皮干细胞蛋白抗体
xy-0268R Neurobeachin蛋白激酶锚定蛋白抗体
xy-11317R Neuroserpin丝氨酸或半胱氨酸蛋白水解酶抑制蛋白1抗体
xy-4800R NG2黑色素瘤硫酸软骨素蛋白多糖抗体
xy-11181R Neuroligin 3突触细胞粘附分子3抗体
xy-11323R Neuroglycan C跨膜硫酸软骨素蛋白聚糖C抗体
xy-11324R Nova1神经肿瘤Nova1抗原抗体
xy-9558R NTALB淋巴细胞链接激活蛋白抗体
xy-11193R NSMase2中性鞘磷脂2抗体
xy-11202R NR2E1核受体蛋白NR2E1抗体
xy-11171R NXPH2神经外营养蛋白2抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上,标准品和样品中的 E2F1与单抗结合,加入生物素化的抗人 E2F1 ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入底物工作液显蓝色,最后加终止液硫酸,在 450nm 处测 OD 值,E2F1 浓度与 OD 值成正比
珠子对照样品外每个样品中加入一抗,抗体的量按照以往经验来加,1-10ug的抗体/25ugDNA效果较好。3加入20ul的proteinA/G珠子(预先用超声处理成为单链的鲱精DNA和BSA吸附,详见步骤4.3a)到所有样品总,4°C摇转IP过夜。3a将蛋白A/G珠子与单链鲱精DNA进行预处理。如果同时使用蛋白A珠子和蛋白G珠子,等体积混合这两种珠子使用RIPA溶液洗3次。除去RIPA溶液,加入单链鲱精DNA到珠子终浓度为75ng/μl,再用BSA将珠子终浓度定到0.1μg/μl。加入两倍珠子
Analysis of RB Action in DNA Damage Checkpoint Response
checkpoint response: (1) transcriptional repression of E2F-regulated genes (cyclin A reporter assay); (2) induction of cell cycle arrest (Brd-U incorporation assay); and (3) inhibition of DNA double-strand break accumulation (phosphorylated-histone H2A.X
技术资料暂无技术资料 索取技术资料





